Skip to main content

Table 1 Results of nerve conductions studies

From: CMTX1 patients’ cells present genomic instability corrected by CamKII inhibitors

  mNCV CMAP
Patient 1 39 m/s 3.4 mV
Patient 2 45 m/s 4.0 mV
Patient 3 32 m/s 1.5 mV
Patient 4 32.4 m/s 5.1 mV
Patient 5 34.1 m/s 1.4 mV
  1. Electrophysiological evaluations were performed on 5 patients with CMTX1, with clinical presentations described in materials and methods. Results of nerve conduction studies in terms of median nerve motor conduction velocity (NCV) and compound muscle action potential amplitudes (CMAP) are presented in the table.